Published in Biochim Biophys Acta on December 07, 1981
Iron uptake by human upper small intestine microvillous membrane vesicles. Indication for a facilitated transport mechanism mediated by a membrane iron-binding protein. J Clin Invest (1990) 0.96
Characterization of an integral protein of the brush border membrane mediating the transport of divalent metal ions. Biophys J (2000) 0.81
Na+ modulates carrier-mediated Fe2+ transport through the erythroid cell membrane. Biochem J (1991) 0.75
Iron transport and storage proteins. Annu Rev Biochem (1980) 6.22
Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun (1995) 3.43
Stoichiometric and site characteristics of the binding of iron to human transferrin. J Biol Chem (1978) 2.63
Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients. Crit Care Med (2000) 2.33
Microbial glycolipids: possible virulence factors that scavenge oxygen radicals. Proc Natl Acad Sci U S A (1989) 2.21
Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect Immun (1996) 2.15
Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta (1972) 2.13
Restoration of norepinephrine-modulated contextual memory in a mouse model of Down syndrome. Sci Transl Med (2009) 1.94
Iron, atherosclerosis, and ischemic heart disease. Arch Intern Med (1999) 1.93
Defective iron homeostasis in beta 2-microglobulin knockout mice recapitulates hereditary hemochromatosis in man. J Exp Med (1996) 1.78
Packed-cell volume in elite athletes. Lancet (1998) 1.75
Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial. Neurology (2012) 1.67
Bicarbonate and the binding of iron to transferrin. J Biol Chem (1967) 1.62
Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women. Circulation (1999) 1.54
Iron-chelating agents in non-iron overload conditions. Ann Intern Med (1994) 1.50
Polypharmacy in fatal clozapine-associated agranulocytosis. Lancet (1991) 1.50
Iron metabolism in the erythrophagocytosing Kupffer cell. Hepatology (1988) 1.49
The effect of recombinant human erythropoietin on hemostasis, fibrinolysis, and blood rheology in autologous blood donors. J Lab Clin Med (1994) 1.40
Haematocrit in elite athletes. Int J Sports Med (1999) 1.39
Deferiprone for thalassaemia. Lancet (2000) 1.39
Lipid peroxidation of human granulocytes (PMN) and monocytes by iron complexes. Br J Haematol (1989) 1.39
The effect of oral iron supplementation on erythropoiesis in autologous blood donors. Transfusion (1992) 1.39
[Iron deficiency, a simple diagnosis?]. Ned Tijdschr Geneeskd (1993) 1.38
Correlation of exposure to various respiratory pathogens with farmer's lung disease. J Allergy Clin Immunol (1977) 1.38
Citrate-mediated exchange of FE3+ among tranferrin molecules. Biochem Biophys Res Commun (1968) 1.37
A new role for the transferrin receptor in the release of iron from transferrin. Biochemistry (1991) 1.36
Distribution of iron between the binding sites of transferrin in serum: methods and results in normal human subjects. Blood (1979) 1.33
Detection of melanin-like pigments in the dimorphic fungal pathogen Paracoccidioides brasiliensis in vitro and during infection. Infect Immun (2001) 1.31
The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J Biol Chem (1984) 1.31
T1 and T2 of ferritin solutions: effect of loading factor. Magn Reson Med (1996) 1.28
The fate of cytoplasmic vanadium. Implications on (NA,K)-ATPase inhibition. J Biol Chem (1979) 1.27
Studies on the binding of iron to transferrin and conalbumin. J Biol Chem (1966) 1.26
Chelate mediated transfer of iron from transferrin to desferrioxamine. Br J Haematol (1976) 1.23
The iron-binding function of transferrin in iron metabolism. Semin Hematol (1977) 1.23
Receptor-modulated iron release from transferrin: differential effects on N- and C-terminal sites. Biochemistry (1991) 1.20
Precipitating antibodies to farmer's lung antigens in a Wisconsin farming population. Am Rev Respir Dis (1981) 1.18
The anion requirement for iron release from transferrin is preserved in the receptor-transferrin complex. Biochemistry (1993) 1.17
Receptor-induced switch in site-site cooperativity during iron release by transferrin. Biochemistry (1992) 1.15
Delayed hypersensitivity to beryllium compounds. J Immunol (1973) 1.12
Relaxometry and magnetometry of ferritin. Magn Reson Med (1998) 1.11
Facilitation of Fe(II) autoxidation by Fe(3) complexing agents. Biochim Biophys Acta (1973) 1.11
The chromium, manganese, and cobalt complexes of transferrin. J Biol Chem (1969) 1.10
Structure and function of transferrin. Prog Hematol (1975) 1.10
Brainstem reflex circuits revisited. Brain (2004) 1.09
Transferrin receptors and the uptake and release of iron by isolated hepatocytes. Hepatology (1981) 1.08
Organic dust exposures from work in dairy barns. Am Ind Hyg Assoc J (1998) 1.08
A topodiagnostic investigation on body lateropulsion in medullary infarcts. Neurology (2005) 1.08
Hydroxyl radical formation and iron-binding proteins. Stimulation by the purple acid phosphatases. J Biol Chem (1987) 1.07
Iron release from recombinant N-lobe and mutants of human transferrin. Biochemistry (1995) 1.07
Increased exposure to cryptosporidia among dairy farmers in Wisconsin. J Infect Dis (1993) 1.05
Iron release from human monocytes after erythrophagocytosis in vitro: an investigation in normal subjects and hereditary hemochromatosis patients. Blood (1998) 1.05
The interaction of transferrin with isolated hepatocytes. Biochim Biophys Acta (1980) 1.04
The stability constants of the Fe3+ conalbumin complexes. Biochem Biophys Res Commun (1968) 1.04
Inducibility of transferrin receptors on friend erythroleukemic cells. Science (1977) 1.04
Interactions between isolated hepatocytes and Kupffer cells in iron metabolism: a possible role for ferritin as an iron carrier protein. Hepatology (1988) 1.04
Molecular characteristics of the transferrin-receptor complex of the rabbit reticulocyte. J Supramol Struct (1978) 1.03
Farmer's lung disease among farmers with precipitating antibodies to the thermophilic actinomycetes: a clinical and immunologic study. J Allergy Clin Immunol (1978) 1.02
The relative efficiency of time-to-threshold and rate of change in longitudinal data. Contemp Clin Trials (2011) 1.02
Primary receptor-recognition site of human transferrin is in the C-terminal lobe. J Biol Chem (1994) 1.02
Iron metabolism and erythropoiesis after surgery. Br J Surg (1998) 1.01
Iron-donating properties of transferrin. Biochemistry (1975) 1.01
Alzheimer's disease therapeutic trials: EU/US Task Force report on recruitment, retention, and methodology. J Nutr Health Aging (2012) 1.00
Zero-field splittings of iron complexes of transferrins. J Biol Chem (1972) 1.00
Inhibition of human immunodeficiency virus type 1 replication in human mononuclear blood cells by the iron chelators deferoxamine, deferiprone, and bleomycin. J Infect Dis (2000) 0.99
Listeria monocytogenes meningitis and decreased phagocytosis associated with iron overload. Br Med J (Clin Res Ed) (1982) 0.99
Accumulation of iron in erythroblasts of patients with erythropoietic protoporphyria. Eur J Clin Invest (1993) 0.99
Functional equivalence of the two iron-binding sites of human transferrin. Nature (1975) 0.99
Fe3+ coordination and redox properties of a bacterial transferrin. J Biol Chem (2000) 0.98
Acquired angioedema, autoimmune hemolytic anemia, and lymphoma: resolution after therapy. Clin Immunol Immunopathol (1980) 0.98
Iron and inflammatory bowel disease. Aliment Pharmacol Ther (2001) 0.98
Mucosal uptake, mucosal transfer and retention of iron, measured by whole-body counting. Scand J Haematol (1979) 0.97
High rat food vitamin E content improves nerve function in streptozotocin-diabetic rats. Eur J Pharmacol (1999) 0.97
Blood-induced joint damage: a human in vitro study. Arthritis Rheum (1999) 0.97
Activation of the complement sequence by extracts of bacteria and fungi associated with hypersensitivity pneumonitis. J Allergy Clin Immunol (1976) 0.96
The amount of ferritin and hemosiderin in the livers of patients with iron-loading diseases. Hepatology (1983) 0.96
The role of the anion-binding site of transferrin in its interaction with the reticulocyte. Biochim Biophys Acta (1973) 0.95
Subcellular localization of ferritin and iron taken up by rat hepatocytes. Biochem J (1989) 0.95
Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes. Eur J Clin Invest (2000) 0.95
A kinetically active site in the C-lobe of human transferrin. Biochemistry (1997) 0.95
The concept of iron bioavailability and its assessment. Eur J Nutr (1999) 0.95
HLA-B8 in sarcoidosis. Ann Allergy (1981) 0.94
Pulsed electron paramagnetic resonance studies of the copper complexes of transferrin. J Biol Chem (1979) 0.94
The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev (1995) 0.94
Uptake of ferritin and iron bound to ferritin by rat hepatocytes: modulation by apotransferrin, iron chelators and chloroquine. Biochim Biophys Acta (1989) 0.93
Spectroscopic evidence for a difference between the iron-binding sites of conalbumin. J Biol Chem (1973) 0.93
Iron overload and heart fibrosis in mice deficient for both beta2-microglobulin and Rag1. Am J Pathol (2000) 0.93
Transferrin receptor-independent uptake of differic transferrin by human hepatoma cells with antisense inhibition of receptor expression. Hepatology (1996) 0.93
Bacterial iron enhances oxygen radical-mediated killing of Staphylococcus aureus by phagocytes. Infect Immun (1990) 0.93
Functional defects in phagocytic cells from patients with iron overload. J Infect (1984) 0.93
Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem (1998) 0.93
Iron absorption in erythropoietin-treated haemodialysis patients: effects of iron availability, inflammation and aluminium. Nephrol Dial Transplant (1998) 0.93
Adaptive response of iron absorption to anemia, increased erythropoiesis, iron deficiency, and iron loading in beta2-microglobulin knockout mice. Blood (1998) 0.92
The effect of lithium carbonate on lymphocyte, granulocyte, and platelet function. Cancer (1980) 0.92
Anti-HIV effect of iron chelators: different mechanisms involved. J Clin Virol (2001) 0.92
Low-dose aspirin does not prevent thrombovascular accidents in low-risk haemodialysis patients during treatment with recombinant human erythropoietin. Nephrol Dial Transplant (1994) 0.92
1H NMR studies of porcine uteroferrin. Magnetic interactions and active site structure. J Biol Chem (1983) 0.91
Normal iron absorption and decreased red cell iron uptake in the aged. Blood (1979) 0.90
Decreased iron absorption in patients with active rheumatoid arthritis, with and without iron deficiency. Ann Rheum Dis (1988) 0.90
The EPR spectra of copper transferrin complexes at 2-4 GHZ. Biochim Biophys Acta (1982) 0.90
Preparation and properties of a single-sited fragment from the C-terminal domain of human transferrin. Biochim Biophys Acta (1985) 0.89